Press releaseGlobe Newswire
ENvue Medical
NAOV · NASDAQ
$1.03−$2.32 (−69.25%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseGlobe Newswire
ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line
- NewsVandana Singh
EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal
- Press releaseGlobe Newswire
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
- Press releaseGlobe Newswire
ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription
- Press releaseGlobe Newswire
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
- Press releaseGlobe Newswire
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026
- Press releaseGlobe Newswire
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
- Press releaseGlobe Newswire
ENvue Medical's UroShield® Kit Secures Reimbursement in the UK
- Press releaseBusiness Wire
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and 'FEED'
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseBusiness Wire
NanoVibronix Issues Letter to Shareholders
- Press releaseBusiness Wire
NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities
- Press releaseBusiness Wire
NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- NewsAvi Kapoor
Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
- Press releaseBusiness Wire
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio
- Press releaseBusiness Wire
NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology
- Press releaseBusiness Wire
NanoVibronix Announces Reverse Stock Split
- Press releaseBusiness Wire
NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseBusiness Wire
NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation
- Press releaseBusiness Wire
NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Dow Rises Over 50 Points; US Inflation Rate Increases In May
- Press releaseBusiness Wire
ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System
- Press releaseBusiness Wire
NanoVibronix Announces CEO Transition
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseBusiness Wire
NanoVibronix Responds to False Post
- Press releaseBusiness Wire
Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseBusiness Wire
NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants
- NewsAvi Kapoor
Crude Oil Falls Over 2%; US Retail Sales Increase 0.1% In April
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Dow Tumbles 150 Points; Walmart Earnings Top Views
- Press releaseBusiness Wire
NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants
- Press releaseBusiness Wire
NanoVibronix Announces Results from UroShield™ Case Series
- NewsChris Katje
EXCLUSIVE: April's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.